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Abstract Protein misfolding and aggregation are linked to sev-
eral degenerative diseases and are responsible for the formation
of bacterial inclusion bodies. Roles of molecular chaperones in
promoting protein deposition have been speculated but not prov-
en in vivo. We have investigated the involvement of individual
chaperones in inclusion body formation by producing the mis-
folding-prone but partially soluble VP1LAC protein in chaper-
one null bacterial strains. Unexpectedly, the absence of a func-
tional GroEL signi¢cantly reduced aggregation and favoured
the incidence of the soluble protein form, from 4 to 35% of
the total VP1LAC protein. On the other hand, no regular in-
clusion bodies were then formed but more abundant small ag-
gregates up to 0.05 Wm3. Contrarily, in a DnaK3 background,
the amount of inclusion body protein was 2.5-fold higher than in
the wild-type strain and the average volume of the inclusion
bodies increased from 0.25 to 0.38 Wm3. Also in the absence
of DnaK, the minor fraction of soluble protein appears as highly
proteolytically stable, suggesting an inverse connection between
proteolysis and aggregation managed by this chaperone. In sum-
mary, GroEL and DnaK appear as major antagonist controllers
of inclusion body formation by promoting and preventing, re-
spectively, the aggregation of misfolded polypeptides. GroEL
might have, in addition, a key role in driving the protein transit
from the soluble to the insoluble cell fraction and also in the
opposite direction. Although chaperones ClpB, ClpA, IbpA and
IbpB also participate in these processes, the impact of the re-
spective null mutations on bacterial inclusion body formation is
much more moderate.
4 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The folding into a precise three-dimensional structure is a
requisite for protein activity. However, under heat shock and
other stresses protein folding can be impaired and folding
intermediates then tend to associate through exposed hydro-
phobic patches. Individual polypeptide molecules are thus
being trapped into growing oligomeric aggregates lacking
the biological activity. These protein aggregates exhibit a dif-
ferent molecular organisation, such as a ¢bril structure in the
amyloid plaques [1] and a particulate organisation in bacterial
inclusion bodies [2]. The precise mechanics of the intermolec-
ular interactions driving the aggregation seeding process re-
main poorly understood.
Molecular chaperones are essential for the correct folding
of a signi¢cant fraction of cellular proteins under both phys-
iological and stress conditions [3], acting in a complex net-
work as a main defence against protein aggregation. In this
cooperative context, some chaperones exhibit a holding activ-
ity, preventing polypeptides from aggregation [4^6], while
others show a complementary folding role to assist refolding
and solubilisation from aggregates [7,8]. Moreover, chaper-
ones also minimise aggregation by mediating the degradation
of proteins that cannot be properly folded [9].
The speci¢c contribution of particular chaperones to this
multifunctional folding network has been only partially iden-
ti¢ed. Aggregates formed upon thermal stress in bacteria have
represented a useful model for such functional scrutiny. Upon
heat shock, DnaK has been observed as a major protector of
aggregation but also as a key element for the solubilisation of
small aggregates, in close cooperation with ClpB [6,10^12]. On
the other hand, small heat-shock proteins IbpA and IbpB
protect heat-denatured proteins from irreversible aggregation
[13,14], while GroEL is a main folder element in the multi-
chaperone network [15].
Interestingly, it has been observed that GroEL facilitates
the recruitment of PrPC into pre-existing PrPSc aggregates
[16] and it also promotes PrPC aggregation in the absence
of any template [17]. In the context of conformational dis-
eases, this could be indicative of a role of molecular chaper-
ones not only in the prevention and reversion of aggregation
but also in the active formation of structured aggregates. In
this regard, perinuclear elements called aggresomes, in which
cell chaperones participate as well, have been proven to pro-
mote active protein deposition in eukaryotic cells [18,19],
these functional complexes being observed as a protective
mechanism against the cellular toxicity of misfolded proteins
[20]. No analogous mechanism for cell-driven protein deposi-
tion has been identi¢ed in thermally stressed prokaryotic cells.
However, a speci¢c type of aggregates, named inclusion
bodies (IBs), is formed by an excluding seeding process in
speci¢c sites of the cell cytoplasm [21], and shows an impor-
tant extent of inner molecular organisation [2]. The building
of such organised structures could be compatible with the
existence of bacterial mechanisms favouring protein deposi-
tion. To explore in more detail this possibility and the even-
tual participation of molecular chaperones we have here ana-
lysed the impact of null mutations in main chaperone-
encoding genes on the formation of IBs. Interestingly,
DnaK and GroEL appear as antagonist elements in the IB-
forming process. While the absence of DnaK results in bigger
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protein deposits, con¢rming the role of this chaperone in pre-
venting aggregation, the de¢ciency in GroEL reduces the ex-
tent of protein aggregation and prevents IBs from being as-
sembled from numerous small protein aggregation cores that
remain free and independent in the cell cytoplasm.
2. Materials and methods
2.1. Bacterial strains, plasmids, and culture conditions
Mutant Escherichia coli strains were derivative from MC4100
(araD139 v(argF-lac)U169 rpsL150 relA1 £bB5301 deoC1 ptsF25
rbsR). Inactivating mutations in chaperone genes had been introduced
by P1 transduction into MC4100 background to generate strains
JGT3 (vclpB: :kan), JGT4 (clpA: :kan), JGT6 (zjd: :Tn10 groES30),
JGT17 (vibp: :kan), JGT20 (dnak756 thr: :Tn10), JGT32 (dnaK756
thr: :Tn10 vclpB: :kan) [22] and BB4564 (groEL140 zjd: :Tn10
zje: :6Spcr/Strr) [6,23]. BB4565 (groEL44 zjd: :Tn10 zje: :Kan) con-
tained another inactivating mutation in the groEL gene, rendering
the same GroEL3 phenotype as BB4564 [6,23]. All these strains
were transformed with plasmid pJVP1LAC, encoding the misfold-
ing-prone VP1LAC hybrid protein (an amino terminal L-galactosidase
fusion) under the control of the lambda pR and pL lytic promoters and
the temperature-sensitive CI857 repressor [24]. Upon thermal induc-
tion of gene expression from 28 to 42‡C, VP1LAC is produced as IBs
in the cytoplasm of E. coli [21]. For some experiments, the related
plasmid pJVP1 encoding the non-fused foot-and-mouth disease virus
VP1 protein was also used [24]. Luria^Bertani (LB) medium [25] plus
the required antibiotics were used for bacterial culture. 3 h after in-
duction of VP1LAC gene expression, samples were taken to separate
the soluble cell fraction and IBs for analysis. For the in vivo solubi-
lisation experiments, protein synthesis was arrested at this time by
both cloramphenicol addition (up to 200 Wg/ml) and temperature
downshift to 28‡C. Then, IB protein evolution was analysed in West-
ern blot by using an anti-L-galactosidase rabbit serum. L-Galactosi-
dase activity was determined as described previously [26]. All the
experiments were performed at least in triplicate, and a representative
one is shown in the ¢gures.
2.2. Separation of the soluble and insoluble protein fractions and
IB puri¢cation
Cells concentrated up to a pre-de¢ned OD550 were ice-jacketed and
disrupted by sonication in a Braun Labsonic U device for 10 min with
a needle titanium probe. Sonication settings were 20 kHz and 50 W
acoustic power with 0.5 s cycles of alternate sonication and resting.
Samples were then centrifuged for 15 min at 12 000 rpm, the soluble
fraction was stored at 380‡C until used and the pellet was treated for
IB puri¢cation by repeated detergent treatment as described in [27].
Soluble cell fraction and IBs were analysed by polyacrylamide gel
electrophoresis and protein bands were detected in Western blot by
using a polyclonal anti-L-galactosidase serum.
2.3. Light scattering and IB image analysis
Light scattering measurements were made in an Aminco SLM 8000
spectro£uorometer on puri¢ed IBs. Scattered light (320 nm) was col-
lected at an angle of 90‡ of the incident light by integrating in the
315^325 nm window. For image analysis, samples of VP1LAC-pro-
ducing cells 3 h after the temperature up-shift were ¢xed with 0.1%
formaldehyde and stored at 4‡C until use. Photographs were taken at
U1000 magni¢cation factor in a Zeiss (Axioplan D-7082) optical
microscope and images processed as described in detail in [21] for
IB volume determination. More than 100 individual cells were
scanned from each strain for statistics.
3. Results
3.1. Protein aggregation as IBs is enhanced in the absence of
DnaK but largely reduced in a GroEL3 background
The mechanics of the in vivo IB construction and disinte-
gration [28] are still unknown. However, since speci¢c chap-
erones such as DnaK and ClpB have been proven to detach
polypeptides in vitro and also in vivo from certain types of
aggregates, these cell proteins (and eventually other chaper-
ones) were presumed to also actively participate in IB solubi-
lisation [29]. Therefore, we investigated the construction and
deconstruction of IBs in a relevant set of E. coli mutant
strains (Table 1). Protein aggregation was determined by light
scattering of puri¢ed IBs upon recombinant expression of the
model hybrid gene VP1LAC. In addition, the amount of
VP1LAC protein in the isolated IBs was determined by West-
ern blot (Fig. 1). In all these strains, the recombinant protein
was the main component of the aggregates up to about 90%
of the total protein (data not shown). The coincidence be-
tween the pro¢les of total aggregated protein and VP1LAC
amounts (Fig. 1C) indicates that the relative presence of the
recombinant protein in the aggregates is not signi¢cantly dif-
ferent within the mutant strains and also compared to the
wild type, and con¢rms that VP1LAC is a reliable reporter
protein for the analysis of IB formation in di¡erent genetic
backgrounds. On the other hand, the amount of VP1LAC IB
protein was signi¢cantly higher in the dnaK mutant than in
the rest of the strains, and in groES, groEL140 and clpB dnaK
mutant strains clearly lower than that found in the wild type.
The amount of IB protein in the dnaK and groEL140 mutants
was also determined for a recombinant, non-fused VP1 pro-
tein of 23 kDa, rendering the same pro¢le as that found for
VP1LAC (data not shown).
Inversely, the soluble VP1LAC protein in the groEL3 back-
ground was more than six-fold higher than in the wild-type
cells, while in the dnaK mutant the soluble form of VP1LAC
was hardly detected (Fig. 2A). Minor variations in the
VP1LAC fractioning were observed in the rest of the strains.
3.2. Inactivation of DnaK minimises proteolysis of VP1LAC
Interestingly, a VP1LAC degradation fragment of 116 kDa
commonly observed in recombinant cells (named ‘L-gal-like’)
was not detected in any of the dnaK mutants but in all the
other strains (Fig. 2B). This suggested that the absence of
DnaK would render VP1LAC more proteolytically stable.
In GroEL3 cells, in which most of the recombinant protein
Table 1
E. coli strains used in this work
Strain Genotype Phenotype Reference
MC4100 araD139 v(argF-lac)U169 rpsL150 relA1 £bB5301 deoC1 ptsF25 rbsR wt [22]
JGT3 MC4100 vclpB: :kan ClpB3 [22]
JGT4 MC4100 clpA: :kan ClpA3 [22]
JGT6 MC4100 zjd: :Tn10 groES30 GroES3 [22]
JGT17 MC4100 vibp1: :kan IbpA3, IbpB3 [22]
JGT20 MC4100 dnaK756 thr: :Tn10 DnaK3 [22]
JGT32 MC4100 dnaK756 thr: :Tn10 vclpB: :kan ClpB3DnaK3 [22]
BB4564 MC4100 groEL44 zdj: :Tn10 zje: :6Spcr GroEL3 [6]
BB4565 MC4100 groEL140 zdj: :Tn10 zje: :kan GroEL3 [6]
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is soluble, proteolytic stability might be impaired, as observed
by the ratio between the truncated and full-length forms of
the protein. On the other hand, the divergent impact of groEL
and dnaK mutations on VP1LAC solubility is clearly observed
in the protein fractioning as depicted in Fig. 2C.
3.3. ClpB and DnaK null mutations have a moderate impact on
the in vivo solubilisation of IB protein
The formation of bacterial IBs is the result of an unbal-
anced equilibrium between protein aggregation and solubilisa-
tion under overproduction conditions [27]. In addition, it has
been suggested that chaperones DnaK and ClpB might par-
ticipate in IB disintegration through the removal of IB pro-
teins [29]. Therefore, the inverse in£uence of dnaK and groEL
(and also groES) null mutations as deduced from the cellular
amount of IB protein (Fig. 1) could be due to either a de¢-
cient prevention of aggregation and/or a less e⁄cient protein
removal from IBs. In particular, the high IB protein amounts
found in the dnaK mutant strain might be caused by either a
favoured protein deposition or by a restricted rate of protein
solubilisation in the absence of DnaK. To discriminate be-
tween these possibilities, we determined the loss of IB protein
upon arresting protein synthesis in cells containing already
formed IBs (Table 2). In all the tested genetic backgrounds
a lower percentage of protein is removed from IBs than in the
wild-type strain (63%), ranging from intermediate (clpA,
groES, ibpAB ; 42^49%) to high (groEL ; 32%) negative impact
on the VP1LAC release process. In dnaK mutants the amount
of released protein within a given time period is comparable
to that produced by the groEL140 mutation. This indicates
that the higher extent of VP1LAC aggregation observed in
dnaK compared to the wild type and also to the GroEL3
strains (Fig. 1) is not merely due to a failure in protein sol-
ubilisation but rather to altered aggregation pathways that
favour protein precipitation in the absence of DnaK. Interest-
ingly, GroEL might have a major solubilising activity on IB
protein. This was con¢rmed by the analysis of IB disintegra-
tion also in the GroEL(44)3 background, in which only
around 15% of VP1LAC protein was lost from IBs (data
not shown), a value still lower than that found in the
groEL140 mutant. Note that, in absolute terms, the amount
of protein removed from wild-type IBs does not represent an
upper threshold that could eventually restrict protein solubi-
lisation in strains producing bigger IBs.
3.4. The absence of GroEL impairs protein deposition into IBs
Since DnaK and GroEL chaperones have been proven to
be key elements of the cell protein quality control system [30],
Fig. 1. Amounts of VP1LAC protein in puri¢ed IBs 3 h after induction of VP1LAC gene expression, as measured by Western blot (A) and
light scattering (B) of puri¢ed IBs. The growth curves and ¢nal biomasses were similar in all the strains in the tested time period. The correla-
tion between both parameters is also shown (C). Statistics are r=0.94; P6 0.01.
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Fig. 2. Amount of soluble VP1LAC protein 3 h post-induction (A). The intact, full-length VP1LAC fusion of 135 kDa is shown as a black bar
while a main degradation fragment of 116 kDa (L-galactosidase-like) is shown as a white bar. The quotient between the amount of L-galactosi-
dase-like and intact VP1LAC protein is shown as an index of proteolytic susceptibility (B). The fraction of soluble (white bar) and IB (black
bar) VP1LAC protein is also indicated (C). Protein amounts were determined by Western blot of soluble and IB fractions of crude cell ex-
tracts.
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their opposite impact on IB formation was analysed in more
detail. Protein fractioning was monitored in the dnaK and two
groEL mutants plus in the GroES3 strain. Data at both 3 and
5 h post-induction of VP1LAC expression are depicted in Fig.
3. Again, the soluble protein fraction was hardly detectable in
the dnaK mutant but increasingly abundant in both GroEL3
strains (containing either groEL140 or groEL44 inactivating
mutations). Interestingly, the absence of GroES does not re-
sult in a higher amount of soluble protein as it occurs in the
GroEL3 background. The divergent impact of these muta-
tions indicates that the roles of GroEL and GroES in the
processing of VP1LAC are not (at least exclusively) coopera-
tive. In agreement with the abundance of soluble protein in
GroEL3 cells, the L-galactosidase enzymatic activity in both
groEL mutants was higher than in the rest of the tested strains
(data not shown). This fact proves that, although the absence
of GroEL favours the occurrence of soluble VP1LAC, this
chaperone is dispensable for its complete refolding to the na-
tive conformation.
3.5. The regular IB architecture is not reached in GroEL null
mutants
The morphological features of IBs formed under the genetic
backgrounds depicted in Fig. 3 were determined 3 h after
induction of VP1LAC gene expression. In wild-type cultures,
cells bearing more than two IBs were rarely observed while
those containing only one were abundant, representing over
80% of the IB-bearing cells (Fig. 4). This is in agreement with
previous observations on the Lon-de¢cient strain BL21 pro-
ducing VP1LAC [21]. However, in the groEL140 mutant, cells
containing more than two particles represented more than
60% of the cell population in which aggregation was observed
(Fig. 5A), with an average of 5.1 particles per cell. A mere
inhibition of cell division as occurring in this strain could not
account for the higher number of aggregates since in DnaK3
cells, also showing ¢lamentation, the statistics resemble those
of the wild-type strain. In addition, the average volume of IBs
formed in DnaK3 is signi¢cantly higher than those produced
in the wild-type cells (0.38 versus 0.25 Wm3), while the aggre-
gates observed in GroEL3 cells only measure 0.05 Wm3 (Fig.
5B). We cannot exclude the existence of smaller aggregates in
this last strain escaping from the microscopic observation.
GroES3 IBs are in the range of 0.18 Wm3, close to data ob-
tained from the wild-type cells.
4. Discussion
IBs are a particular type of protein aggregates formed in
bacterial cells upon expression of recombinant genes at high,
non-physiological rates [31]. Structurally, they are porous [32],
composed of heterogeneously folded chains [2,33] and organ-
ised into a particulate structure [2]. Protein deposition as IBs
occurs simultaneously to cell-mediated solubilisation of IB
protein [34], the volumetric IB growth being the result of an
unbalanced equilibrium of both events that can be redirected
towards disintegration upon the arrest of protein synthesis
[27]. An important part of the protein removed from IBs
undergoes proteolytic attack and is degraded, while a fraction
reaches a fully functional form [27]. On the other hand, the
formation of IBs and in general protein aggregates is largely
enhanced in strains devoid of the protease Lon [24,35]. Alto-
gether, these observations prompt us to observe IBs as an
intermediate and transient status of misfolded protein deeply
integrated in the cell quality control, in which proteases and
chaperones play interconnected roles. Protein aggregation as
IBs would then be the result of the inability of chaperones and
proteases to process high amounts of misfolded protein, which
remains clustered until it can be released to re-enter the qual-
ity control. However, the speci¢c cellular proteins involved in
the speci¢c processing of IB polypeptides remained unidenti-
¢ed and the speci¢c features of the IB structure allowing the
dynamic protein transfer from and to IBs are still to be elu-
cidated.
Recent research on protein aggregation has revealed that a
bi-chaperone system consisting of DnaK and ClpB has the
capacity to solubilise heat-aggregated proteins (reviewed in
[29]). The participation of these and other relevant chaperones
in IB formation has been analysed in strains containing null
Table 2
VP1LAC released from IBs in the absence of protein synthesis
Phenotype Lost VP1LAC IBa (%) Lost VP1LAC IBa (W/ml)
wt 63 105.8
ClpB3 64 124.5
ClpA3 42 73.9
GroES3 49 10.34
IbpA IbpB3 44 51.7
DnaK3 34 139.4
ClpB3 DnaK3 35 17.8
GroEL(140)3 32 23.9
aMaximal amount of VP1LAC protein lost from IB within a 3 h
period after the arrest of protein synthesis. Note that a certain ex-
tent of protein re-aggregation can occur under these conditions [27].
Fig. 3. Partitioning of VP1LAC protein at 3 h (panel A) and 5 h (panel B) after induction of gene expression. Protein was quanti¢ed by West-
ern blot for the soluble (black bar) and IB (white bar) fractions of crude cell extracts.
FEBS 27022 13-2-03
M.M. Carrio¤, A. Villaverde/FEBS Letters 537 (2003) 215^221218
mutations in the encoding genes (Table 1). As was to be ex-
pected, the absence of a functional DnaK protein resulted in
enhanced amounts of aggregated VP1LAC protein (Figs. 1
and 2) and in large IBs (Figs. 4 and 5). However, this fact
is not only depending on impaired solubilisation activities,
since the capacity of the DnaK3 strain to remove protein
from IB is comparable to that observed in a GroEL3 back-
ground (Table 2), in which the deposition of insoluble protein
is not particularly favoured (Fig. 1). Interestingly, in the ab-
sence of a functional DnaK, the amount of remaining soluble
VP1LAC protein is hardly detectable (Fig. 2). Moreover, a
commonly observed VP1LAC degradation product, namely
the L-galactosidase-like fragment, is absent in both DnaK3
and DnaK3ClpB3 cells but not in ClpB3 (Fig. 2), suggesting
that DnaK could be involved in VP1LAC degradation by
delivering folding intermediates to proteases. In this context,
the DnaK co-chaperone DnaJ has been proven to be involved
in the selective breakdown of misfolded proteins by promot-
ing the formation of protease^substrate complexes [9,36].
Also, DnaK itself is necessary for the degradation of partic-
ular misfolded proteins and involved in the general proteolytic
processing in E. coli [3,37].
These results indicate that prevention of aggregation and
the favouring of degradation (rather than the disaggregating
properties) are the main activities of DnaK involved in IB
formation. In this context, the absence of ClpB, participating
in the bi-chaperone network for reversion of heat denatura-
tion [6,11], a¡ects neither the total amount of IB protein (Fig.
1) nor the e⁄ciency of protein release from IBs (Table 2). It is
not obvious why IB formation is impaired in the double
DnaK3ClpB3 mutant (Fig. 1) and why DnaK and ClpB do
not cooperate for the dissolution of IBs, while such coordi-
nated activity has been proven on other types of aggregates
di¡erent from IBs. The low disaggregating e⁄ciency of
DnaK-ClpB on big-sized aggregates [38] could account for
IBs being recalcitrant to disintegration mediated by these
chaperones. On the other hand, the molecular organisation
of polypeptide chains in heat- or chemically-denatured protein
does not need to be comparable to that of IB protein, where
cell chaperones IbpA and IbpB and others are also present
and associated with aggregated polypeptides. Therefore, the
refolding mechanics and requirements for solubilisation of
di¡erent aggregates could be dissimilar. In this context, sev-
eral chaperone-inactivating mutations have observable impair-
ing e¡ects on the release of IB protein (Table 2), proving that
this process is the result of cooperative or complementing
activities of the multichaperone network.
Unexpectedly, in a GroEL-de¢cient background, IB forma-
tion is largely impaired (Fig. 1), the VP1LAC protein remain-
ing soluble in the cell cytoplasm (Figs. 2 and 3) and retaining
enzymatic activity (data not shown). On the other hand, in the
absence of this chaperone, regular IBs are not formed (Fig. 4)
despite the fact that the total VP1LAC amounts are compa-
rable to those found in wild-type cells (Fig. 3). Contrarily,
small and abundant protein aggregates are observed in the
cell cytoplasm (Figs. 4 and 5), indicative of a failure in the
seeding process in the IB construction. This role of GroEL in
promoting protein aggregation and the organisation of small
protein aggregates in higher organised structures such as IBs
would be irrespective of its well-described folding activities for
Fig. 4. Micrographs of mutant cells 3 h after the induction of VP1LAC gene expression. The GroEL3 cell picture corresponds to strain
BB4564 (groEL140).
Fig. 5. Number of refractile IB particles per cell, namely one (black bar), two (light grey bar) and more than two (dark grey bar) (A). The
average number of aggregates per cell has been calculated for GroES3 (3.0), DnaK3 (3.6) and GroEL(140)3 (5.1). The average IB volume is
represented in panel B.
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which GroES is required [39]. The divergent impact of
GroEL- and GroES-inactivating mutations (Figs. 2^5) indi-
cates a lack of cooperation of these proteins in IB formation.
In this context, GroEL without GroES can mediate PrP ag-
gregation in vitro [17]. On the other hand, GroEL is also
involved in protein removal from IBs, since the de¢ciency in
this chaperone largely minimises the release of IB protein
(Table 2). These results support the idea that GroEL might
drive protein transfer not only from the soluble to the insolu-
ble cell fraction but also inversely.
The folding activities of GroEL-GroES are limited by the
size of the protein substrate to be encapsulated up to 55 kDa
[40], and VP1LAC is a homotetrameric hybrid L-galactosidase
enzyme of about 135 kDa per monomer [24]. However, bind-
ing of GroEL to proteins larger than 80 kDa for their folding
has been reported [41]. In addition, GroEL co-puri¢es with
VP1LAC from crude cell extracts [42] and, in the absence of
GroES, it forms in vitro complexes with denatured L-galacto-
sidase [43]. These observations prove not only the dispensabil-
ity of GroES for GroEL activities leading to IB formation but
also the capacity of GroEL to interact with large-sized pro-
teins for processes distinguishable from the encapsulated fold-
ing. Although the nature of these interactions still remains
unsolved, GroEL association with large-mass substrates would
prevent GroES from sealing the GroEL cavity [39]. Moreover,
the fact that FMDV VP1 (23 kDa) IBs are also poorly formed
in a GroEL3 context (data not shown), indicates that the
involvement of GroEL in these IB managing activities might
be independent of the molecular mass of the protein. On the
other hand, the ine⁄cient VP1LAC solubilisation from IBs in
the GroEL3 background (Table 2) suggests that this protein
might mediate the transit of misfolded protein from the solu-
ble to the insoluble but also from the insoluble to the soluble
states. This would be in agreement with previous experiments
performed in vitro and revealing an unusual behaviour of
GroEL, in which this chaperone prevented the aggregation
of denatured L-galactosidase, but in the presence of ATP, it
instead stimulated its deposition into aggregates [43].
In summary, the construction of bacterial IBs is the result
of a multichaperone network acting on both aggregation and
disaggregation pathways, in which DnaK and GroEL play
critical but antagonistic roles. While DnaK prevents IB for-
mation by reducing aggregation and promoting proteolysis of
misfolded proteins, GroEL operates protein transit between
soluble and insoluble cell fractions and positively participates
in IB formation. The antagonism of DnaK and GroEL activ-
ities is amazingly exempli¢ed by the volume reduction in IBs
formed by the human growth hormone, the increase of the IB
number per cell and also the higher amounts of soluble pro-
tein found upon over-expression of dnaK gene along with the
recombinant gene [44], this being a phenotype similar to that
reported here for GroEL-de¢cient mutants. A natural GroEL
IB-seeding activity would be comparable to that driving the
formation of PrP aggregates in vitro and as suggested to occur
in vivo in eukaryotic cells by homologous chaperones during
the course of conformational diseases [16,17]. Therefore,
GroEL (and eventually the generic Hsp60 chaperone family),
in close combination with, or supervised by other cell ele-
ments, would act as a key instrument to minimise the toxicity
associated with the exposition of hydrophobic domains on
misfolded proteins. In bacteria, this protective task might be
at least partially accomplished by IB formation.
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